Vasohibin: the feedback on a new inhibitor of angiogenesis

被引:33
作者
Kerbel, RS
机构
[1] Univ Toronto, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
关键词
D O I
10.1172/JCI200423153
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Angiogenesis is regulated in large part by the balance of various proangiogenic stimulators, such as VEGF, and a diverse group of endogenous inhibitors of angiogenesis, most of which are extrinsic to endothelial cells. With respect to the latter, until recently, none have appeared to be induced as a consequence of a specific, self-regulating, feedback inhibition response. A new inhibitor, called vasohibin, has been uncovered. Vasohibin is selectively induced in endothelial cells by proangiogenic stimulatory growth factors such as VEGF; it appears to operate as an intrinsic and highly specific feedback inhibitor of activated endothelial cells engaged in the process of angiogenesis (see the related article beginning on page 898).
引用
收藏
页码:884 / 886
页数:3
相关论文
共 23 条
[1]   Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy [J].
Bocci, G ;
Francia, G ;
Man, S ;
Lawler, J ;
Kerbel, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) :12917-12922
[2]   How tumors become angiogenic [J].
Bouck, N ;
Stellmach, V ;
Hsu, SC .
ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 :135-174
[3]   CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J].
DAMERON, KM ;
VOLPERT, OV ;
TAINSKY, MA ;
BOUCK, N .
SCIENCE, 1994, 265 (5178) :1582-1584
[4]   Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].
Ferrara, N ;
Hillan, KJ ;
Gerber, HP ;
Novotny, W .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400
[5]  
Filleur S, 2003, CANCER RES, V63, P3919
[6]   In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects [J].
Filleur, S ;
Volpert, OV ;
Degeorges, A ;
Voland, C ;
Reiher, F ;
Clézardin, P ;
Bouck, N ;
Cabon, F .
GENES & DEVELOPMENT, 2001, 15 (11) :1373-1382
[7]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[8]   TUMOR ANGIOGENESIS [J].
FOLKMAN, J .
ADVANCES IN CANCER RESEARCH, 1985, 43 :175-203
[9]   Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression [J].
Hamano, Y ;
Sugimoto, H ;
Soubasakos, MA ;
Kieran, M ;
Olsen, BR ;
Lawler, J ;
Sudhakar, A ;
Kalluri, R .
CANCER RESEARCH, 2004, 64 (05) :1570-1574
[10]   Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [J].
Hanahan, D ;
Bergers, G ;
Bergsland, E .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1045-1047